Literature DB >> 30190987

Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Pierre Nahon1,2,3,1,2,3, Angela Sutton4,5,4,5, Marianne Ziol2,6,7,2,6,7, Jessica Zucman-Rossi2,3,8,9,10,2,3,8,9,10, Jean-Claude Trinchet1,2,3,7,1,2,3,7, Nathalie Ganne-Carrié1,2,3,1,2,3.   

Abstract

Various single nucleotide polymorphisms have been reported to be associated with a higher risk of hepatocellular carcinoma in alcoholic cirrhotic patients. Until now, only common variants conferring a small increase in liver cancer risk have been identified. These inherited factors are able to modulate several biological pathways involved in alcohol-induced hepatocarcinogenesis, such as ethanol metabolism, inflammation, oxidative stress, or iron and lipid homeostasis. How the combination of these variants might collectively define an individual genomic risk prediction is currently being investigated. The other challenge in clinical practice lies in defining how to integrate this genetic information with other clinical parameters so as to refine selection of alcoholic cirrhotic patients according to various classes of hepatocellular carcinoma risk.

Entities:  

Keywords:  alcoholic liver disease; cirrhosis; liver cancer; single nucleotide polymorphisms

Year:  2015        PMID: 30190987      PMCID: PMC6095302          DOI: 10.2217/hep.14.26

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  99 in total

1.  Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Marianne Ziol; Gabriel Thabut; Pierre-Olivier Schischmanoff; Dominique Vidaud; Nathalie Charnaux; Philippe Couvert; Nathalie Ganne-Carrie; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

2.  Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Authors:  Faten Charni; Angela Sutton; Pierre Rufat; Christelle Laguillier; Abdellah Mansouri; Richard Moreau; Nathalie Ganne-Carrié; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Charnaux; Pierre Nahon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

Review 3.  Genetic factors in alcohol metabolism and alcoholism.

Authors:  W F Bosron; T Ehrig; T K Li
Journal:  Semin Liver Dis       Date:  1993-05       Impact factor: 6.115

4.  Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.

Authors:  Pierre Nahon; Angéla Sutton; Dominique Pessayre; Pierre Rufat; Francoise Degoul; Nathalie Ganne-Carrie; Marianne Ziol; Nathalie Charnaux; Gisèle N'kontchou; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand
Journal:  Clin Gastroenterol Hepatol       Date:  2005-03       Impact factor: 11.382

5.  Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.

Authors:  M Schöniger-Hekele; C Müller; M Kutilek; C Oesterreicher; P Ferenci; A Gangl
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 2.566

6.  Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.

Authors:  H Bell; J Jahnsen; E Kittang; N Raknerud; L Sandvik
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

Review 7.  Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.

Authors:  Nathalie Druesne-Pecollo; Bertrand Tehard; Yann Mallet; Mariette Gerber; Teresa Norat; Serge Hercberg; Paule Latino-Martel
Journal:  Lancet Oncol       Date:  2009-02       Impact factor: 41.316

8.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

Review 9.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

10.  Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Jian-Hong Zhong; Xue-Mei You; Wen-Feng Gong; Liang Ma; Yu Zhang; Qin-Guo Mo; Liu-Cheng Wu; Jun Xiao; Le-Qun Li
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.